-
RegMed XB 2022 Annual Meeting
The fourth RegMed XB’s Annual Meeting was held in the Philips Stadion in Eindhoven on 6 and 7 July.
read more
33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine
Promising therapies for patients one step closer. The urgency is high in the field of regenerative medicine. Promising therapies are in the pipeline from the lab to the patient, but a good infrastructure is needed to make this possible.
read more
A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.
Mohammad Rezaeimoghaddam and Frans van de Vosse have published a paper with the title ”Continuum modeling of thrombus formation and growth under different shear rates” in the Journal of Biomechanics.
read more -
Podcast, Leaders in Life Sciences, 18 January 2023: Bernard Mulder
-